checkAd

     213  0 Kommentare Supernus to Participate in Two Upcoming Investor Conferences - Seite 2

    CONTACTS:

    Jack A. Khattar, President and CEO
    Timothy C. Dec, Senior Vice President and CFO
    Supernus Pharmaceuticals, Inc.
    Tel: (301) 838-2591

    Or

    INVESTOR CONTACT:

    Peter Vozzo
    ICR Westwicke
    Office: (443) 213-0505
    Email: peter.vozzo@westwicke.com



    globenewswire
    0 Follower
    Autor folgen
    Seite 2 von 2

    Verfasst von globenewswire
    Supernus to Participate in Two Upcoming Investor Conferences - Seite 2 ROCKVILLE, Md., March 06, 2024 (GLOBE NEWSWIRE) - Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced …

    Schreibe Deinen Kommentar

    Disclaimer